XERS News and Press, Xeris Pharmaceuticals Inc. From 09/14/23

2023-09-14 21:41:10 ET Summary Xeris Biopharma Holdings Inc. is making strong progress on the top line and is on track to achieve a positive cash flow breakeven point in 2023. The company holds a substantial number of patents globally, contributing to its success in the pharmaceut...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a f...

2023-09-08 17:10:24 ET Gainers: Vigil Neuroscience ( NASDAQ: VIGL ) +7% . Tenaya Therapeutics ( TNYA ) +4% . CorMedix ( CRMD ) +4% . Xeris Biopharma  ( XERS ) +3% . Avidity Biosciences ( RNA ) +3% . Losers: The L...

2023-08-28 15:12:12 ET If you’re looking to gain an edge in the stock market today, you’ve got to have more than a list of penny stocks to watch. You need to understand how to use the wild volatility that has been created this year to your advantage. Whether there’s...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a f...

2023-08-10 17:18:45 ET Xeris Pharmaceuticals press release ( NASDAQ: XERS ): Q2 revenue of $38M (+50.1% Y/Y) misses by $2.93M . For further details see: Xeris Pharmaceuticals reports Q2 revenue

--News Direct-- Xeris Biopharma chairman and CEO Paul Edick joined Proactive's Stephen Gunnion with details of the company's second-quarter performance, which saw record revenue driven by the success of their products, including Gvoke, Keveyis, and Recorlev. For the quarter, which end...

2023-08-08 11:55:02 ET Xeris Biopharma Holdings, Inc. (XERS) Q2 2023 Results Conference Call August 08, 2023 08:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations Paul Edick - Chairman and Chief Executive Officer Steven P...

Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the release of a thematic report that examines small market cap pharmaceutical companies based on revenue growth and valuation. The report: Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline ex...

2023-08-08 07:06:57 ET Xeris Pharmaceuticals press release ( NASDAQ: XERS ): Q2 GAAP EPS of -$0.14 misses by $0.01 . Revenue of $38.01M (+50.2% Y/Y) beats by $3.17M . “We posted another record quarter of revenue due to the continued strong demand of all ...